SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-023431
Filing Date
2017-11-13
Accepted
2017-11-13 07:40:39
Documents
3
Period of Report
2017-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q3 2017_EARNING RELEASE reta-8k_20171109.htm 8-K 29789
2 EX-99.1 EARNING RELEASE reta-ex991_53.htm EX-99.1 214780
3 GRAPHIC g201711102251126754802.jpg GRAPHIC 18952
  Complete submission text file 0001564590-17-023431.txt   271940
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 171193139
SIC: 2834 Pharmaceutical Preparations